Maxolon

Maxolon

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MAXOLO...
read more
APOHEALTH Cold Relief

APOHEALTH Cold Relief

NOTICE: This Consumer Medicine Information (CMI) i...
read more
APO-Glimepiride

APO-Glimepiride

NOTICE: This Consumer Medicine Information (CMI) i...
read more
APO-Gabapentin tablets

APO-Gabapentin tablets

NOTICE: This Consumer Medicine Information (CMI) i...
read more
Syquet

Syquet

NOTICE: This Consumer Medicine Information (CMI) i...
read more
Sudafed Sinus Day + Night Relief Tablets

Sudafed Sinus Day + Night Relief Tablets

NOTICE: This Consumer Medicine Information (CMI) i...
read more
Test document

Test document

NOTICE: This Consumer Medicine Information (CMI) i...
read more
Chemmart Tramadol

Chemmart Tramadol

NOTICE: This Consumer Medicine Information (CMI) i...
read more
Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy

Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy

ATLANTA, Nov. 17, 2020 /PRNewswire/ — UCB, a...
read more
Epilepsy Meds During Pregnancy May Raise Autism Risk in Child

Epilepsy Meds During Pregnancy May Raise Autism Risk in Child

FRIDAY, Oct. 30, 2020 — Women who take the e...
read more